A. Adamis, L. Aiello, D. Amato, and R. , Angiogenesis and ophthalmic disease, Angiogenesis, vol.3, issue.1, pp.9-14, 1999.
DOI : 10.1023/A:1009071601454

T. Alon, I. Hemo, A. Itin, J. Pe-'er, J. Stone et al., Vascular endothelial growth factor acts as a survival factor for newly formed retinal vessels and has implications for retinopathy of prematurity, Nature Medicine, vol.9, issue.10, pp.1024-1028, 1995.
DOI : 10.1038/356397a0

K. Aulak, M. Miyagi, L. Yan, K. West, D. Massillon et al., Proteomic method identifies proteins nitrated in vivo during inflammatory challenge, Proceedings of the National Academy of Sciences, vol.3, issue.2, pp.12056-12061, 2001.
DOI : 10.1038/35055104

A. Barber, E. Lieth, S. Khin, D. Antonetti, A. Buchanan et al., Neural apoptosis in the retina during experimental and human diabetes. Early onset and effect of insulin., Journal of Clinical Investigation, vol.102, issue.4, pp.783-791, 1998.
DOI : 10.1172/JCI2425

J. Beckman and W. Koppenol, Nitric oxide, superoxide, and peroxynitrite: the good, the bad, and ugly, Am J Physiol, vol.271, pp.1424-1437, 1996.

T. Bek, Transretinal histopathological changes in capillary-free areas of diabetic retinopathy, Acta Ophthalmologica, vol.67, issue.4, pp.409-415, 1994.
DOI : 10.1111/j.1755-3768.1994.tb02787.x

J. Bolanos, A. Almeida, E. Fernandez, J. Medina, J. Land et al., Potential mechanisms for nitric oxide-mediated impairment of brain mitochondrial energy metabolism, Biochemical Society Transactions, vol.25, issue.3, pp.944-949, 1997.
DOI : 10.1042/bst0250944

B. Brune, A. Von-knethen, and K. Sandau, Nitric oxide and its role in apoptosis, European Journal of Pharmacology, vol.351, issue.3, pp.261-272, 1998.
DOI : 10.1016/S0014-2999(98)00274-X

K. Christopherson and D. Bredt, Nitric oxide in excitable tissues: physiological roles and disease., Journal of Clinical Investigation, vol.100, issue.10, pp.2424-2429, 1997.
DOI : 10.1172/JCI119783

A. Collier, J. Mitchell, and B. Clarke, Visual evoked potential and contrast sensitivity function in diabetic retinopathy., BMJ, vol.291, issue.6490, p.248, 1985.
DOI : 10.1136/bmj.291.6490.248

P. Amore, Mechanisms of retinal and choroidal neovascularization, Invest Ophthalmol Vis Sci, vol.35, pp.3974-3979, 1994.

O. Dembinska, L. Rojas, D. Varma, S. Chemtob, and P. Lachapelle, Graded contribution of retinal maturation to the development of oxygen-induced retinopathy in rats, Invest Ophthalmol Vis Sci, vol.42, pp.1111-1118, 2001.

A. El-asrar, S. Desmet, A. Meersschaert, L. Dralands, L. Missotten et al., Expression of the inducible isoform of nitric oxide synthase in the retinas of human subjects with diabetes mellitus, American Journal of Ophthalmology, vol.132, issue.4, pp.551-556, 2001.
DOI : 10.1016/S0002-9394(01)01127-8

A. Fulton and R. Hansen, Photoreceptor function in infants and children with a history of mild retinopathy of prematurity, Journal of the Optical Society of America A, vol.13, issue.3, pp.566-571, 1996.
DOI : 10.1364/JOSAA.13.000566

A. Fulton, R. Hansen, R. Petersen, and D. Vanderveen, The Rod Photoreceptors in Retinopathy of Prematurity, Archives of Ophthalmology, vol.119, issue.4, pp.499-505, 2001.
DOI : 10.1001/archopht.119.4.499

H. Garban and B. Bonavida, Nitric Oxide Inhibits the Transcription Repressor Yin-Yang 1 Binding Activity at the Silencer Region of the Fas Promoter: A Pivotal Role for Nitric Oxide in the Up-Regulation of Fas Gene Expression in Human Tumor Cells, The Journal of Immunology, vol.167, issue.1, pp.75-81, 2001.
DOI : 10.4049/jimmunol.167.1.75

E. Garvey, J. Oplinger, E. Furfine, R. Kiff, F. Laszlo et al., 1400W Is a Slow, Tight Binding, and Highly Selective Inhibitor of Inducible Nitric-oxide Synthase in Vitro and in Vivo, Journal of Biological Chemistry, vol.272, issue.8, pp.4959-4963, 1997.
DOI : 10.1074/jbc.272.8.4959

O. Geyer, J. Almog, M. Lupu-meiri, M. Lazar, and Y. Oron, Nitric oxide synthase inhibitors protect rat retina against ischemic injury, FEBS Lett, vol.374, pp.399-402, 1995.

O. Goureau, F. Regnier-ricard, and Y. Courtois, Requirement for Nitric Oxide in Retinal Neuronal Cell Death Induced by Activated M??ller Glial Cells, Journal of Neurochemistry, vol.156, issue.6, pp.2506-2515, 1999.
DOI : 10.1046/j.1471-4159.1999.0722506.x

S. Greenacre and H. Ischiropoulos, Tyrosine nitration: Localisation, quantification, consequences for protein function and signal transduction, Free Radical Research, vol.277, issue.6, pp.541-581, 2001.
DOI : 10.1080/01635588609513875

B. Halliwell, K. Zhao, and M. Whiteman, Nitric oxide and peroxynitrite. The ugly, the uglier and the not so good, Free Radical Research, vol.1, issue.1, pp.651-669, 1999.
DOI : 10.1002/ana.410420416

P. Lachapelle, O. Dembinska, L. Rojas, J. Benoit, G. Almazan et al., Persistent functional and structural retinal anomalies in newborn rats exposed to hyperoxia, Canadian Journal of Physiology and Pharmacology, vol.77, issue.1, pp.48-55, 1999.
DOI : 10.1139/y98-150

T. Lam, A. Abler, and M. Tso, Apoptosis and caspases after ischemia-reperfusion injury in rat retina, Invest Ophthalmol Vis Sci, vol.40, pp.967-975, 1999.

J. Macmicking, C. Nathan, G. Hom, N. Chartrain, D. Fletcher et al., Altered responses to bacterial infection and endotoxic shock in mice lacking inducible nitric oxide synthase, Cell, vol.81, issue.4, pp.1170641-650, 1995.
DOI : 10.1016/0092-8674(95)90085-3

J. Macmicking, Q. Xie, and C. Nathan, NITRIC OXIDE AND MACROPHAGE FUNCTION, Annual Review of Immunology, vol.15, issue.1, pp.323-350, 1997.
DOI : 10.1146/annurev.immunol.15.1.323

L. Macmillan-crow and J. Thompson, Tyrosine Modifications and Inactivation of Active Site Manganese Superoxide Dismutase Mutant (Y34F) by Peroxynitrite, Archives of Biochemistry and Biophysics, vol.366, issue.1, pp.82-88, 1999.
DOI : 10.1006/abbi.1999.1202

C. Nathan, Inducible nitric oxide synthase: what difference does it make?, Journal of Clinical Investigation, vol.100, issue.10, pp.2417-2423, 1997.
DOI : 10.1172/JCI119782

A. Palmowski, E. Sutter, B. Jr, M. Fung, and W. , Mapping of retinal function in diabetic retinopathy using the multifocal electroretinogram, Invest Ophthalmol Vis Sci, vol.38, pp.2586-2596, 1997.

J. Penn, V. Rajaratnam, R. Collier, and A. Clark, The effect of an angiostatic steroid on neovascularization in a rat model of retinopathy of prematurity, Invest Ophthalmol Vis Sci, vol.42, pp.283-290, 2001.

D. Reisner, R. Hansen, O. Findl, R. Petersen, and A. Fulton, Dark-adapted thresholds in children with histories of mild retinopathy of prematurity, Invest Ophthalmol Vis Sci, vol.38, pp.1175-1183, 1997.

F. Sennlaub, Y. Courtois, and O. Goureau, Inducible nitric oxide synthase mediates the change from retinal to vitreal neovascularization in ischemic retinopathy, Journal of Clinical Investigation, vol.107, issue.6, pp.717-725, 2001.
DOI : 10.1172/JCI10874
URL : https://hal.archives-ouvertes.fr/inserm-00150818

L. Smith, E. Wesolowski, A. Mclellan, S. Kostyk, D. Amato et al., Oxygen-induced retinopathy in the mouse, Invest Ophthalmol Vis Sci, vol.35, pp.101-111, 1994.

D. Sun, C. Coleclough, L. Cao, X. Hu, S. Sun et al., Reciprocal stimulation between TNF-?? and nitric oxide may exacerbate CNS inflammation in experimental autoimmune encephalomyelitis, Journal of Neuroimmunology, vol.89, issue.1-2, pp.122-130, 1998.
DOI : 10.1016/S0165-5728(98)00124-6

J. Wolter, Diabetic Retinopathy, American Journal of Ophthalmology, vol.51, issue.5, pp.1123-1139, 1961.
DOI : 10.1016/0002-9394(61)91802-5

F. Yamakura, H. Taka, T. Fujimura, and K. Murayama, Inactivation of Human Manganese-superoxide Dismutase by Peroxynitrite Is Caused by Exclusive Nitration of Tyrosine 34 to 3-Nitrotyrosine, Journal of Biological Chemistry, vol.273, issue.23, pp.14085-14089, 1998.
DOI : 10.1074/jbc.273.23.14085